pioglitazone has been researched along with mifepristone in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chao, D; Chen, CH; Ho, ML; Huang, HT; Hung, SH; Wang, C; Wang, GJ; Wu, P; Yeh, CH | 1 |
| Kakuta, H; Sugimoto, Y; Yamamoto, A | 1 |
1 review(s) available for pioglitazone and mifepristone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for pioglitazone and mifepristone
| Article | Year |
|---|---|
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Pioglitazone and dexamethasone induce adipogenesis in D1 bone marrow stromal cell line, but not through the peroxisome proliferator-activated receptor-gamma pathway.
Topics: Adipogenesis; Animals; Bone Marrow Cells; Cell Line; Cell Lineage; Dexamethasone; Dose-Response Relationship, Drug; Gene Expression Profiling; Gene Expression Regulation; Genes, Reporter; Glucocorticoids; Hormone Antagonists; Hypoglycemic Agents; Mice; Mice, Inbred BALB C; Mifepristone; Oligonucleotide Array Sequence Analysis; Pioglitazone; Pluripotent Stem Cells; PPAR gamma; Receptors, Glucocorticoid; Signal Transduction; Stromal Cells; Thiazolidinediones | 2008 |
Involvement of glucocorticoid receptor activation on anti-inflammatory effect induced by peroxisome proliferator-activated receptor γ agonist in mice.
Topics: Anilides; Animals; Carrageenan; Dexamethasone; Edema; Female; Mice; Mice, Inbred ICR; Mifepristone; Models, Animal; Pioglitazone; PPAR gamma; Pyridinium Compounds; Receptors, Glucocorticoid; Retinoid X Receptors; Signal Transduction; Styrenes; Thiazolidinediones | 2014 |